Iradimed (IRMD) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $88.27, -1.23% vs the prior close of $89.37.
- Volume 78.80K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
IRMD dips 1.2% to $88.27. Closed at $88.27, -1.23% vs the prior close of $89.37. Day range $88.10–$90.43, opened at $89.53.
IRMD daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — IRMD dips 1.2% to $88.27
- Closed at $88.27, -1.23% vs the prior close of $89.37. Day range $88.10–$90.43, opened at $89.53.
- Volume was 78.80K shares, 0.7x its 50-day average of 119.18K.
- Price is +2.3% vs its 50-day average ($86.27) and -5.3% vs its 200-day average ($93.21).
- 52-week range $73.02–$107.90; today's close sits at 44% of that range, 18.2% below the 52-week high.
Oct 15, 2026 — IRMD dips 0.5% to $89.37
- Closed at $89.37, -0.51% vs the prior close of $89.83. Day range $89.12–$91.05, opened at $90.33.
- Volume was 80.60K shares, 0.7x its 50-day average of 120.53K.
- Price is +3.5% vs its 50-day average ($86.33) and -4.2% vs its 200-day average ($93.25).
- 52-week range $72.45–$107.90; today's close sits at 48% of that range, 17.2% below the 52-week high.
Oct 14, 2026 — IRMD ends flat (+0.2%) to $89.83, a 1-month high, 6 up days in a row
- Closed at $89.83, +0.20% vs the prior close of $89.65. Day range $89.39–$90.43, opened at $89.61.
- Volume was 73.50K shares, 0.6x its 50-day average of 123.61K — lighter than usual.
- Price is +4.0% vs its 50-day average ($86.38) and -3.7% vs its 200-day average ($93.30).
- 52-week range $71.34–$107.90; today's close sits at 51% of that range, 16.7% below the 52-week high.
- That makes 6 straight gains.
Oct 13, 2026 — IRMD ends flat (+0.2%) to $89.65, a 1-month high, 5 up days in a row
- Closed at $89.65, +0.20% vs the prior close of $89.47. Day range $88.05–$90.46, opened at $89.93.
- Volume was 94.70K shares, 0.8x its 50-day average of 126.01K.
- Price is +3.7% vs its 50-day average ($86.45) and -3.9% vs its 200-day average ($93.33).
- 52-week range $71.34–$107.90; today's close sits at 50% of that range, 16.9% below the 52-week high.
- That makes 5 straight gains.
Oct 12, 2026 — IRMD rises 2.3% to $89.47, a 1-month high, 4 up days in a row
- Closed at $89.47, +2.31% vs the prior close of $87.45. Day range $86.86–$89.67, opened at $87.82.
- Volume was 111.50K shares, 0.9x its 50-day average of 129.94K.
- Price is +3.4% vs its 50-day average ($86.49) and -4.2% vs its 200-day average ($93.37).
- 52-week range $71.34–$107.90; today's close sits at 50% of that range, 17.1% below the 52-week high.
- That makes 4 straight gains.
Oct 9, 2026 — IRMD rises 1.8% to $87.45, a 1-month high, 3 up days in a row
- Closed at $87.45, +1.83% vs the prior close of $85.88. Day range $85.56–$87.48, opened at $85.56.
- Volume was 68.90K shares, 0.5x its 50-day average of 131.01K — lighter than usual.
- Price is +1.1% vs its 50-day average ($86.51) and -6.4% vs its 200-day average ($93.41).
- 52-week range $71.34–$107.90; today's close sits at 44% of that range, 19.0% below the 52-week high.
- That makes 3 straight gains.
Oct 8, 2026 — IRMD rises 0.5% to $85.88
- Closed at $85.88, +0.48% vs the prior close of $85.47. Day range $84.58–$86.55, opened at $85.59.
- Volume was 91.60K shares, 0.7x its 50-day average of 131.41K.
- Price is -0.9% vs its 50-day average ($86.67) and -8.1% vs its 200-day average ($93.46).
- 52-week range $71.34–$107.90; today's close sits at 40% of that range, 20.4% below the 52-week high.
Oct 7, 2026 — IRMD rises 0.8% to $85.47
- Closed at $85.47, +0.77% vs the prior close of $84.82. Day range $83.84–$86.77, opened at $84.55.
- Volume was 197.90K shares, 1.5x its 50-day average of 129.72K.
- Price is -1.6% vs its 50-day average ($86.84) and -8.6% vs its 200-day average ($93.51).
- 52-week range $71.34–$107.90; today's close sits at 39% of that range, 20.8% below the 52-week high.
Oct 6, 2026 — IRMD dips 1.9% to $84.82
- Closed at $84.82, -1.91% vs the prior close of $86.47. Day range $84.34–$87.08, opened at $87.08.
- Volume was 118.60K shares, 0.9x its 50-day average of 128.70K.
- Price is -2.5% vs its 50-day average ($87.02) and -9.3% vs its 200-day average ($93.57).
- 52-week range $70.80–$107.90; today's close sits at 38% of that range, 21.4% below the 52-week high.
Oct 5, 2026 — IRMD rises 1.3% to $86.47
- Closed at $86.47, +1.25% vs the prior close of $85.40. Day range $85.00–$86.61, opened at $85.28.
- Volume was 77.00K shares, 0.6x its 50-day average of 128.75K — lighter than usual.
- Price is -0.9% vs its 50-day average ($87.23) and -7.6% vs its 200-day average ($93.61).
- 52-week range $70.80–$107.90; today's close sits at 42% of that range, 19.9% below the 52-week high.
Oct 2, 2026 — IRMD ends flat (+0.1%) to $85.40
- Closed at $85.40, +0.12% vs the prior close of $85.30. Day range $84.53–$86.27, opened at $86.14.
- Volume was 119.50K shares, 0.9x its 50-day average of 128.02K.
- Price is -2.3% vs its 50-day average ($87.39) and -8.8% vs its 200-day average ($93.66).
- 52-week range $69.47–$107.90; today's close sits at 41% of that range, 20.9% below the 52-week high.
IRMD latest news & SEC filings
Every SEC filing by or about IRMD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kiani Joe E converted options/RSUs into 698 shares on Sep 23, 2026; now holds 698
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Allen Monty K sold 405 shares at $86.35 (≈$34.97K) on Sep 3, 2026
- Allen Monty K sold 1,014 shares at $86.44 (≈$87.65K) on Sep 3, 2026
- Allen Monty K sold 405 shares at $86.35 (≈$34.97K) on Sep 3, 2026
- Allen Monty K sold 1,014 shares at $86.44 (≈$87.65K) on Sep 3, 2026
- Allen Monty K sold 405 shares at $86.35 (≈$34.97K) on Sep 3, 2026
- Allen Monty K sold 1,014 shares at $86.44 (≈$87.65K) on Sep 3, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 3, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 18, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 31, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $20.47M (prior year $20.41M) (+0.3% vs Jun 30, 2025)
- Net income: $5.22M (prior year $5.77M) (-9.6% vs Jun 30, 2025)
- Diluted EPS: $0.41 (prior year $0.45) (-8.9% vs Jun 30, 2025)
Jul 31, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 28, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Jun 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade IRMD
- Last results release: May 1, 2026 (8-K Item 2.02). Previous ones: Feb 10, 2026, Nov 3, 2025, Aug 1, 2025. Based on that rhythm, the next report is likely around Jul 31, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.05% (largest 4.9%).
- Liquidity: about 125.58K shares (≈$11.09M) trade per day on average.
- 52-week position: $88.27 vs a range of $73.02–$107.90 (44% of the range).
- Dividends: last ex-dividend date Aug 14, 2026 ($0.2/share); 5 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Monty K Allen sold 405 shares on Sep 3, 2026.
- Latest filings: 10-Q Jul 31, 2026; 8-K Jul 31, 2026; 8-K Jun 24, 2026.
- Share count: 12.79M shares outstanding (Jul 31, 2026), +0.5% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
IRMD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 89.53 | 90.43 | 88.10 | 88.27 | 78.80K |
| Oct 15, 2026 | 90.33 | 91.05 | 89.12 | 89.37 | 80.60K |
| Oct 14, 2026 | 89.61 | 90.43 | 89.39 | 89.83 | 73.50K |
| Oct 13, 2026 | 89.93 | 90.46 | 88.05 | 89.65 | 94.70K |
| Oct 12, 2026 | 87.82 | 89.67 | 86.86 | 89.47 | 111.50K |
| Oct 9, 2026 | 85.56 | 87.48 | 85.56 | 87.45 | 68.90K |
| Oct 8, 2026 | 85.59 | 86.55 | 84.58 | 85.88 | 91.60K |
| Oct 7, 2026 | 84.55 | 86.77 | 83.84 | 85.47 | 197.90K |
| Oct 6, 2026 | 87.08 | 87.08 | 84.34 | 84.82 | 118.60K |
| Oct 5, 2026 | 85.28 | 86.61 | 85.00 | 86.47 | 77.00K |
| Oct 2, 2026 | 86.14 | 86.27 | 84.53 | 85.40 | 119.50K |
| Oct 1, 2026 | 86.20 | 87.42 | 84.74 | 85.30 | 174.70K |
| Sep 30, 2026 | 87.06 | 87.40 | 85.82 | 86.22 | 138.80K |
| Sep 29, 2026 | 86.60 | 87.11 | 85.40 | 86.46 | 204.80K |
| Sep 28, 2026 | 85.76 | 87.73 | 85.12 | 86.66 | 150.70K |
| Sep 25, 2026 | 85.20 | 86.24 | 84.77 | 85.76 | 146.40K |
| Sep 24, 2026 | 86.18 | 87.20 | 84.57 | 85.20 | 123.00K |
| Sep 23, 2026 | 86.60 | 87.90 | 85.68 | 86.35 | 164.10K |
| Sep 22, 2026 | 81.98 | 86.69 | 81.98 | 86.51 | 176.50K |
| Sep 21, 2026 | 82.29 | 82.81 | 81.51 | 82.46 | 120.10K |
About Iradimed
Iradimed (IRMD) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in ORLANDO, FL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1325618.
IRMD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Monty K Allen | Director | Sep 8, 2026 |
| James B Hawkins | Director | Dec 15, 2025 |
| Joe E Kiani | Director | Sep 25, 2026 |
| Hilda Frederique Scharen-Guivel | Director | Jun 4, 2026 |
| Roger E. Susi | CEO, President, Chairman | Jun 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jeff Chiprin | Chief Commercial Officer | Mar 5, 2026 |
| John Glenn | CFO | Jun 23, 2026 |
| Roger E. Susi | CEO, President, Chairman | Jun 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | Monty K Allen | Sale | 405 | $86.35 |
| Sep 3, 2026 | Monty K Allen | Sale | 1,014 | $86.44 |
| Sep 3, 2026 | Monty K Allen | Sale | 405 | $86.35 |
| Sep 3, 2026 | Monty K Allen | Sale | 1,014 | $86.44 |
| Sep 3, 2026 | Monty K Allen | Sale | 405 | $86.35 |
| Sep 3, 2026 | Monty K Allen | Sale | 1,014 | $86.44 |
| Sep 3, 2026 | Monty K Allen | Sale | 405 | $86.35 |
| Sep 3, 2026 | Monty K Allen | Sale | 1,014 | $86.44 |
| Jun 4, 2026 | Hilda Frederique Scharen-Guivel | Sale | 1,766 | $95.00 |
| Jun 4, 2026 | Hilda Frederique Scharen-Guivel | Sale | 1,234 | $95.00 |
| Jun 4, 2026 | Hilda Frederique Scharen-Guivel | Sale | 1,766 | $95.00 |
| Jun 4, 2026 | Hilda Frederique Scharen-Guivel | Sale | 1,234 | $95.00 |
| Jun 4, 2026 | Hilda Frederique Scharen-Guivel | Sale | 1,766 | $95.00 |
| Jun 4, 2026 | Hilda Frederique Scharen-Guivel | Sale | 1,234 | $95.00 |
| Jun 4, 2026 | Hilda Frederique Scharen-Guivel | Sale | 1,766 | $95.00 |
IRMD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $83.81M | $22.48M | 1.75 | $24.95M |
| Dec 31, 2024 | $73.24M | $19.23M | 1.50 | $25.62M |
| Dec 31, 2023 | $65.56M | $17.19M | 1.35 | $13.47M |
| Dec 31, 2022 | $53.30M | $12.83M | 1.02 | $10.04M |
| Dec 31, 2021 | $41.81M | $9.33M | 0.74 | $11.26M |
Latest balance sheet: total assets $114.97M, total liabilities $13.23M, cash $59.08M (as of Jun 30, 2026).
IRMD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| May 1, 2026 | 8-K Item 2.02 (results) | $87.15 |
| Feb 10, 2026 | 8-K Item 2.02 (results) | $105.15 |
| Nov 3, 2025 | 8-K Item 2.02 (results) | $84.11 |
| Aug 1, 2025 | 8-K Item 2.02 (results) | $66.17 |
| May 5, 2025 | 8-K Item 2.02 (results) | $52.30 |
| Feb 13, 2025 | 8-K Item 2.02 (results) | $55.40 |
| Jan 10, 2025 | 8-K Item 2.02 (results) | $56.59 |
| Oct 31, 2024 | 8-K Item 2.02 (results) | $49.27 |
| Aug 1, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
| Feb 8, 2024 | 8-K Item 2.02 (results) | — |
| Nov 3, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on IRMD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.